1. Home
  2. AGIO vs TRN Comparison

AGIO vs TRN Comparison

Compare AGIO & TRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • TRN
  • Stock Information
  • Founded
  • AGIO 2007
  • TRN 1933
  • Country
  • AGIO United States
  • TRN United States
  • Employees
  • AGIO N/A
  • TRN N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • TRN Railroads
  • Sector
  • AGIO Health Care
  • TRN Industrials
  • Exchange
  • AGIO Nasdaq
  • TRN Nasdaq
  • Market Cap
  • AGIO 2.3B
  • TRN 2.3B
  • IPO Year
  • AGIO 2013
  • TRN N/A
  • Fundamental
  • Price
  • AGIO $36.78
  • TRN $28.12
  • Analyst Decision
  • AGIO Buy
  • TRN Hold
  • Analyst Count
  • AGIO 6
  • TRN 1
  • Target Price
  • AGIO $57.00
  • TRN $24.00
  • AVG Volume (30 Days)
  • AGIO 779.8K
  • TRN 487.5K
  • Earning Date
  • AGIO 10-30-2025
  • TRN 10-30-2025
  • Dividend Yield
  • AGIO N/A
  • TRN 4.26%
  • EPS Growth
  • AGIO N/A
  • TRN N/A
  • EPS
  • AGIO 11.13
  • TRN 1.14
  • Revenue
  • AGIO $40,875,000.00
  • TRN $2,519,800,000.00
  • Revenue This Year
  • AGIO $28.19
  • TRN N/A
  • Revenue Next Year
  • AGIO $152.14
  • TRN $7.24
  • P/E Ratio
  • AGIO $3.31
  • TRN $21.91
  • Revenue Growth
  • AGIO 30.57
  • TRN N/A
  • 52 Week Low
  • AGIO $23.42
  • TRN $22.38
  • 52 Week High
  • AGIO $62.58
  • TRN $39.83
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 48.43
  • TRN 51.43
  • Support Level
  • AGIO $34.97
  • TRN $27.87
  • Resistance Level
  • AGIO $37.91
  • TRN $28.83
  • Average True Range (ATR)
  • AGIO 1.67
  • TRN 0.56
  • MACD
  • AGIO -0.21
  • TRN -0.09
  • Stochastic Oscillator
  • AGIO 48.57
  • TRN 31.01

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About TRN Trinity Industries Inc.

Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

Share on Social Networks: